Inhibition of lysoPAF acetyltransferase activity by flavonoids

Inflammation Research

Volumn 45, Issue 11, 1996, Pages 546-549

  Yanoshita, R ^a   Chang, H W ^b   Son, K H ^c   Kudo, I ^d   Samejima, Y ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Yeungnam University   (South Korea)

^c Andong National University   (South Korea)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Choline acetyltransferase; Flavonoid; LysoPAF acetyltransferase; Platelet activating factor; RBL 2H3 cell

Indexed keywords

1 O ALKYLGLYCERO 3 PHOSPHORYLCHOLINE; ACYLTRANSFERASE; ANTIALLERGIC AGENT; APIGENIN; CALCIMYCIN; CHOLINE ACETYLTRANSFERASE; ENZYME INHIBITOR; ERIODICTYOL; FLAVONOID; KAEMPFEROL; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; PLANT EXTRACT; QUERCETIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; LEUKOCYTE; MASTOCYTOMA; NONHUMAN; RAT;

EID: 0029904989     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02342225     Document Type: Article

References (19)

1. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Ann Rev Biochem 1986;55:483-509.
2. Braquet P, Toqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor. Pharmacol Rev 1987;39:97-145.
3. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochem Biophys Acta 1995;1254:231-49.
4. Middleton Jr. E, Kandaswani C. Effects of flavonoids on immune and inflammatory cell functions. Biochem Pharmacol 1992;43:1167-79.
5. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-8.
6. Son K-H, Park J-O, Chung K-C, Chang H-W, Kim J-S et al. Flavonoids from the aerial parts of Lonicera japonica. Arch Pharm Res 1992;15:365-70.
7. Lenihan DJ, Lee T-C. Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes. Biochem Biophys Res Commun 1984;120:834-9.
8. White HL, Falson LD. Inhibition of lyso-PAF:acetyl-CoA acetyltransferase by salicylates and other compounds. Prostaglandins 1988;35:939-44.
9. Bligh EG, Dyer WJ. A rapid quantitative method of total lipid extraction and purification. Can J Biochem Physiol 1959;37: 911-9.
10. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem 1975;24:407-9.
11. Endo N, Kobayashi F, Fujii O, Nagoya T, Shiratori Y. Influence of various conditions of the environment on growth curves, blood components, organ weight and bacterial flora of SPF rats. Exp Anim 1971;20:7-13.
12. Lynch JM, Lotner GZ, Betz SJ, Henson PM. The release of a platelet-activating factor by stimulated rabbit neutrophils. J Immunol 1979;123:1219-36.
13. Hirafuji M, Nave JF. Platelet-activating factor (PAF-acether) formation in rat basophilic leukemia cells stimulated by ionophore A 23187. Agents Actions 1987;22:159-64.
14. Smith JC, Cavallito CJ, Foldes FF. Choline acetyltransferase inhibitors: a group of styryl-pyridine analogs. Biochem Pharmacol 1967;16:2438-41.
15. Nieto ML, Velasco S, Sanchez-Crespo M. Modulation of acetyl-CoA:1-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PAF) acetyltransferase in human polymorphonuclears. J Biol Chem 1988;263:4607-11.
16. Ninio E, Joly F, Hieblot C, Bessou G, Mencia-Huerta JM, Benveniste J. Biosynthesis of PAF-acether: role for a phosphorylation-dependent activation of acetyltransferase in antigen-stimulated mouse mast cells. J Immunol 1987;139:154-60.
17. Yamazaki R, Sugatani J, Fujii I, Kuroyanagi M, Umehara K, Ueno A, et al. Development of a novel method for determination of acetyl-CoA:1-alkyl-sn-grycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors. Biochem Pharmacol 1994;47: 995-1006.
18. 2 and acylation of lysophospholipids: the major regulators for platelet activating factor production in rat neutrophils. J Biochem 1995;118:442-7.
19. Bourgain R, Andries R, Mencia-Huerta J, Braquet C, Braquet P. The autogeneration of endogenous PAF-acether in in vivo arterial thrombosis follows the remodeling pathway and is inhibited by specific PAF-antagonists BN 52111 and BN 52115. In: Abstracts of the 3rd international conference on platelet-activating factor and structurally related alkyl ether lipids, Tokyo, Japan, 1989, May 8-12:198.